Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
NCT ID: NCT00955214
Last Updated: 2010-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
250 participants
INTERVENTIONAL
2009-04-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels
NCT00371748
Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent
NCT00300157
Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients
NCT00462631
Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease
NCT00704145
Japan-Drug Eluting Stents Evaluation; a Randomized Trial
NCT00708669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2.5mm Paclitaxel-eluting stent
TAXUS Liberté paclitaxel-eluting coronary stent system
diameter is 2.5mm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAXUS Liberté paclitaxel-eluting coronary stent system
diameter is 2.5mm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Females who are not pregnant
3. Patients who present with angina symptoms or myocardial ischemia
4. Patients available for post-procedural observation and coronary angiography at 24 months
5. Patients who have signed patient informed consent
6. Lesion which is eligible for only one 2.5mm paclitaxel-eluting stent
7. De novo lesion or non-stented restenosed lesion
Exclusion Criteria
2. Patients with significant allergic reaction to contrast medium
3. Chronic total occlusion
4. Lesion with TIMI0
5. Lesion which is needed more than two stents
6. Patients with chronic renal failure (SCr\>3.0mg/dl) -
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Society for Advancement of Coronary Intervention Research
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Society for Advancement of Coronary Intervention Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenya Nasu, MD
Role: PRINCIPAL_INVESTIGATOR
Toyohashi Heart Center
Yuji Oikawa, MD
Role: PRINCIPAL_INVESTIGATOR
Cardiovascular institute hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Japanese red cross nagoya daiichi hospital
Nagoya, Aichi-ken, Japan
Higashi Cardiovascular clinic
Toyohashi, Aichi-ken, Japan
Toyohashi Heart Center
Toyohashi, Aichi-ken, Japan
Kokura memorial hospital
Kitakyushu, Fukuoka, Japan
Hoshi general hospital
Kōriyama, Fukushima, Japan
Southen tohoku research institute for neuroscience
Kōriyama, Fukushima, Japan
Gunma prefectural cardiovascular center
Maebashi, Gunma, Japan
Asahikawa medical college hospital
Asahikawa, Hokkaido, Japan
Hakodate central general hospital
Hakodate, Hokkaido, Japan
Shinko kakogawa hospital
Kakogawa, Hyōgo, Japan
Okamoto general hospital
Uji, Kyoto, Japan
Miyagi cardiovascular and respiratory center
Kurihara, Miyagi, Japan
Rinku general medical center
Izumiōtsu, Osaka, Japan
Sakurabashi watanabe hospital
Osaka, Osaka, Japan
Shuwa general hospital
Kasukabe, Saitama, Japan
Kasukabe chuo general hospital
Kasukabe, Saitama, Japan
Kusatsu Heart Center
Kusatsu, Shiga, Japan
Ayase heart hospital
Adachi City, Tokyo, Japan
The cardiovascular institute hospital
Minato, Tokyo, Japan
Tokyo metropolitan police hospital
Naka, Tokyo, Japan
JR tokyo general hospital
Shibuya City, Tokyo, Japan
Tokyo medical university hospital
Shinjuku, Tokyo, Japan
Itabashi Chuo medical center
tabashi City, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008 Dec;1(6):699-709. doi: 10.1016/j.jcin.2008.09.007.
Ahmed WH. Review of the TAXUS Liberte SR paclitaxel-eluting coronary stent. Expert Rev Med Devices. 2007 Mar;4(2):117-20. doi: 10.1586/17434440.4.2.117.
Elezi S, Dibra A, Mehilli J, Pache J, Wessely R, Schomig A, Kastrati A. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. J Am Coll Cardiol. 2006 Oct 3;48(7):1304-9. doi: 10.1016/j.jacc.2006.05.068. Epub 2006 Sep 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SACRA1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.